SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2080And, hey, I own some.keokalani'nui-5/13/2008
2079Agreed completely.rkrw-5/13/2008
2078Sure, I understand a patient's family inferring benefit from a 84% retentionkeokalani'nui-5/13/2008
2077Same thing happens with EVERY AD trial and every time company's imply their rkrw-5/13/2008
2076The CEO actually said this? <i>Remarkably, after 1.5 years in the Phase Ikeokalani'nui-5/13/2008
2075cc transcript: seekingalpha.commopgcw-5/7/2008
2074Cancer-Gene Test Boosts Myriad's Sales By MARILYN CHASE May 7, 2008; Page BDoc Bones-5/7/2008
2073Myriad Genetics Reports Results for Third Quarter of Fiscal 2008 Tuesday May 6, mopgcw-5/6/2008
2072nope, 1600...... Message 24522741 That data was promised ages ago, a couple ofscaram(o)uche-4/22/2008
2071Forbes: Attacking Alzheimer's Robert Langreth 04.21.08, 12:00 AM ET The drumopgcw-4/10/2008
2070Genetics - MYGN-NNM Strong Buy - Price 41.33 on Feb. 5 by JMP Securities Molemopgcw-2/10/2008
2069Thanks Clark and Neuro. My heart was trying to read something positive into the fred hayes-2/7/2008
2068Open label extensions seem to be pretty standard with AD drugs these days. For oNeuroInvestment-2/7/2008
2067<i>Clark, hadn't noticed that the P2 has been extended as an open labeClarksterh-2/7/2008
2066Myriad Genetics Considers Expanding Ad Campaign for Cancer-Gene Test By MARILYDoc Bones-2/6/2008
2065Clark, hadn't noticed that the P2 has been extended as an open label trial. fred hayes-2/6/2008
2064Clark, ya, it requires some faith. But that's my style. Since no one can seefred hayes-2/6/2008
2063Thanks Fred. Given that no data appears to have been released it requires a lotClarksterh-2/6/2008
2062Sorry, meant several HUNDRED $ million for the P3s... fred hayes-2/5/2008
2061Clark, here’s some stuff on Elan/Wyeth Bapineuzumab for your reading pleasure. fred hayes-2/5/2008
2060Clark, just on my way out. I'll do some digging on this and post as soon asfred hayes-2/5/2008
2059Fred - Last night I tried to find any public data about Elan's ph iii drug. Clarksterh-2/5/2008
2058FWIW - Flurizan's Effect in Delaying Progression From Mild Cognitive ImpairLJM-2/5/2008
2057<i>Anyway, I wanted to know if you had a reason to be negative on Bap. SouClarksterh-2/4/2008
2056>> roughly equivalent to 1600 << could have been 1200... meaning scaram(o)uche-2/4/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News